Research article

Synthesis of novel dopamine derived multidirectional ligands from cyanuric chloride: structural and antimicrobial studies

Ziya Erdem Koç1, Mustafa Onur Aladag2[*], Ahmet Uysal2

1Department of Chemistry, Faculty of Science, Selçuk University, 42031 Konya, Turkey

2Vocational School of Health Services, Selçuk University, 42031 Konya, Turkey

EXCLI J 2013;12:Doc396



Two monopodal (2,4-dichloro-6-(3-hydroxytyramine)-1,3,5-triazine) and tripodal (2,4,6-(3-hydroxytyramine)-1,3,5-triazine) s-triazine derivatives were prepared through the reaction of cyanuric chloride (2,4,6-trichloro-1,3,5-triazine) and 3-hydroxytyramine hydrochloride (dopamine hydrochloride). The structures of the compounds were identified by FT-IR, 1H NMR, 13C NMR, thermal analysis and elemental analysis. Their antimicrobial activities were carried out using the broth microdilution method in dimethyl sulfoxide (DMSO): Phosphate Buffered Saline (PBS) against eight bacteria and one yeast. The results of the test were compared with ampicillin. It was determined that CCDOP1, CCDOP3 and DOP have significant antibacterial and antifungal activity. These three chemicals revealed strong antibacterial activity against the E. coli and S. aureus strains used in the study. S. aureus was the most sensitive strain against dopamine hydrochloride and E. coli was the most sensitive bacteria against CCDOP1.

Keywords: cyanuric chloride,dopamine, antimicrobial activity, broth microdilution


Important classes of nitrogenous compounds, such as substituted triazines (Agarwal et al., 2005[2]), pyrimidines (Srivastava et al., 1999[30]), and quinolines (Srivastava et al., 1997[31]), have been synthesized and screened for antimalarial activity (Jensen et al., 2001[10]; Agarwal et al., 2005[1]). In addition, s-triazine derivatives have received considerable attention because of their potent biological activity, for example, as antiprotozoals (Baliani et al., 2005[3]), anticancer drugs (Menicagli et al., 2004[21]), estrogen receptor modulators (Henke et al., 2002[9]), cyclin-dependent kinase inhibitors (Kuo et al., 2005[16]), antivirals (Pandey et al., 2004[26]; Srinivas et al., 2005[29]), and antimalarials (Jensen et al., 2001[10]; Ojha et al., 2011[24]). It has been reported that s-triazine derivatives possess potent antimicrobial activity (Srinivas et al., 2005[29]; McKay et al., 2006[20]; Ghaib et al., 2002[7]; Lübbers et al., 2000[18]; Lebreton et al., 2003[17]; Koç et al., 2010[12]). These derivatives have also been studied as part of research aiming to uncover new natural products with improved biological activities (Kumar and Menon, 2009[15]; Solankee et al., 2010[28]), including antioxidant, anti-human immunodeficiency virus (HIV), and tumor growth inhibition activities (Chang et al., 2010[4]; Naicker et al., 2004[23]). Besides, many of the dopamine containing compounds exhibit antibacterial activities (Hadjipavlou-Litina et al., 2010[8]; Pająk and Kańska, 2006[25]). These are also used as bridging agents to synthesize herbicides and in the production of drugs or polymers (Patel and Patel, 2001[27]; Xie et al., 2007[34]; Koç, 2011[11]). Because of these attractive characteristics, much effort has been devoted to the synthesis of s-triazine derivatives by different groups in the recent years (Koç and Uysal, 2010[13], 2011[14]; Uysal and Koç, 2010[33]; Mooibroek and Gamez, 2007[22]).

The reaction of cyanuric chloride (C3N3Cl3) with 3 or 1 equiv of dopamine hydrochloride in acetone gives the desired monopodal or tripodal in a single step, 2,4-dichloro-6-(3-hydroxytyramine)-1,3,5-triazine, 2,4,6-(3-hydroxytyramine)-1,3,5-triazine and 3-hydroxytyramine hydrochloride, coded to be CCDOP1, CCDOP3 and DOP (Koç, 2011[11]). In this work, we have aimed to make two new s-triazine derivatives by using dopamine hydrochloride. We have called them “monopodal or tripodal s-triazine”. As part of our ongoing research, here we report the characterization and antimicrobial activities of these compounds against several microorganisms.

Materials and Methods

All the other chemicals were purchased from Aldrich. The linking agent, 2,4,6-trichloro-1,3,5-triazine (abbreviated as cyanuric chloride or cc, mp 145-146 oC), was obtained from Aldrich Chem. Co. Cyanuric chloride was purified using recrystallizations from pure petroleum ether (60-90 oC) (Koç, 2011[11]). All solvents and dopamine hydrochloride used were reagent grade and were used without further purification. Melting points were measured using an Optimelt Automated Melting Point System (Digital Image Processing Technology) SRS apparatus. Elemental analyses (C, H, N) were performed using a Leco CHNS-932 model analyzer. 1H NMR spectra were recorded at room temperature with a Varian 400 MHz spectrometer using TMS as an internal standard. FT-IR spectra were recorded with a Perkin-Elmer Spectrum 100 with Universal ATR Polarization Accessory. Thermal analyses were performed on a Shimadzu DTA 50 and TG 50 H on 5 mg samples. The DTA and TG curves were obtained at the heating rate of 10 oC/min from 22 to 900 oC under dry N2. The pH values were measured with a WTW pH 537 pH meter.

Antimicrobial activity

The antimicrobial activity of CCDOP1, CCDOP3 and DOP were determined using eight bacteria and one yeast including, Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 6538, Proteus mirabilis ATCC 43071, Pseudomonas aeruginosa ATCC 15442, Klebsiella oxytoca ATCC 10031, Bacillus cereus ATCC 11778, Listeria monocytogenes Type 2 Pasteur Institute 5434, Streptococcus salivarius RSHE 606 and Candida albicans as test organisms. Bacterial strains and yeast were cultured overnight at 37 oC in nutrient broth. The broth microdilution method was employed for the determination of antimicrobial activity.

The minimal inhibition concentration (MIC) values of the chemical were studied for microorganisms. The inocula of microorganisms were prepared from 12 h broth cultures and suspensions were adjusted to 0.5 McFarland standard turbidity. The 96-well plates were prepared by dispensing into each well 100 µl of nutrient broth. 100 µl from chemicals initially prepared at the concentration of 10000 µg/ml were added into the first wells. Then, 100 µL from the first well was transferred into 11 consecutive wells and diluted and then, 100 µl inocula were distributed to each well. Ampicillin solution was used as the positive control. Then the plates were incubated at appropriate temperatures for 18 h and Candida was incubated for two days. Microbial growth was determined by adding 20 µl of 2,3,5-triphenyl-tetrazolium chloride (0.5 %) after incubation to each well and incubating for 30 min at 37 °C (Maltaş et al., 2010[19]).

Synthesis of compounds

Synthesis procedure for 2,4-dichloro-6-(3-hydroxytyramine)-1,3,5-triazine (CCDOP1)

A solution of dopamine hydrochloride (1.90 g, 10 mmol) in ethanol (50 ml) was added dropwise to a cyanuric chloride suspension made by pouring slurry cyanuric chloride (1.84 g, 10 mmol) in 80 % (v/v) acetone/water (50 ml) and stirring for a further 5 h at 0 oC in an ice bath (Disley et al., 1999[5]; Koç, 2011[11]). The HCl generated during the reaction was neutralized through the periodic addition of NaHCO3 (1.68 g, 20 mmol) to a total of two equivalents in water. Then the mixture was washed with CHCl3 to remove excess cyanuric chloride (Naicker et al., 2004[23]). The reaction was monitored by thin layer chromatography (TLC) (hexane-ethyl acetate, 4:2 v/v) (Teng et al., 2000[32]) until substituted triazine could be detected and at these stages the Fujiwara Test (Fang et al., 2001[6]; Koç, 2011[11]) for dichlorotriazine was positive. The product was then precipitated out of solution by acidifying the pH 4 with (1 M) hydrochloric acid. A light yellow powder solid product was collected by filtration and was washed with cold water (3x100 ml) and acetone (Koç, 2011[11]).

Data for (CCDOP1)

Yield: (72 %); m.p.: 400 oC>; Elemental analysis (Found: C, 43.92; H, 3.33; N, 18.78 %). Calc. for C11H10N4O2Cl2: C, 43.87; H, 3.35; N, 18. 61 %). IR (KBr) νmax/cm-1:3367 (N-H), 3340 (O-H), 2837 (C-H), 1551 (C=N), 1H NMR (400 MHz, DMSO-d6), (δ: ppm): 6.84 (d, 1H, Ar-H), 6.81 (d, 1H, Ar-H), 6.65 (dd, 1H, Ar-H), 5.87 (s, 3H, NH and OH), 3.27 (t, 2H, Ar-C-CH2-N), 2.56 (t, 2H, Ar-CH2-C-N). 13C NMR (100 MHz, DMSO-d6), (δ: ppm): 170.78, 165.18, 164.26, 132.54, 122,44, 116.59, 115.63, 40.23, 35.50.

Synthesis of 2,4,6-(3-hydroxytyramine)-1,3,5-triazine (CCDOP3)

Cyanuric chloride (1.84 g, 10.00 mmol) was dissolved in THF (150 ml). N-ethyldiisopropylamine (DIPEA) (5.22 ml, 30.00 mmol) was added and the two-necked round bottomed flask was cooled to 0 °C. Dopamine hydrochloride (5.67 g, 30.00 mmol) was added portionwise. After the completion of the addition, the suspension mixture was warmed to room temperature and then heated under reflux for 48 h. The solid obtained was filtered under reduced pressure and washed with THF (3x20 ml) and ethanol (3x25 ml) to remove N-ethyldiisopropylamine. The brown product, 2,4,6-(3-hydroxytyramine)-1,3,5-triazine (CCDOP3), was dried overnight at 50 °C under reduced pressure.

Data for(CCDOP3)

Yield: (67 %); m.p.: 360 oC dec.; Elemental analysis (Found: C, 60.70; H, 5.86; N, 15.78 %). Calc. for C27H30N6O6: C, 60.66; H, 5.66; N, 15.72 %). IR (KBr) νmax/cm-1: 3378 (NH), 3358 (OH), 2897 (CH), 1567 (C=N), 1H NMR (400 MHz, DMSO-d6), (δ: ppm): 6.97 (d, 3H, Ar-H), 7.07 (d, 3H, Ar-H), 6.78 (dd, 3H, Ar-H), 5.91 (s, 9H, NH and OH), 3.38 (t, 6H, Ar-C-CH2-N), 2.78 (t, 6H, Ar-CH2-C-N).

Results and Discussion

The usual strategy employed for the synthesis of CCDOP1 and CCDOP3 ligands based on 1,3,5-trichloro-sym-triazine or cyanuric chloride entails reacting the least reactive amine with the first chlorine atom and the most reactive amine with the last chlorine atom, since the chlorine atoms on cyanuric chloride become progressively deactivated as substitution of the triazine ring with amines ensues (Koç, 2011[11]) (Figure 1(Fig. 1)). In the 1H NMR spectra of s-triazine derivatives signals at about 5.87 and 5.91 ppm for compounds CCDOP1 and CCDOP3 were detected, respectively. All signals appeared as singlet and were attributed to the N-H in the CCDOP1 and CCDOP3.

The NH was also identified by FT-IR spectroscopy as a sharp band at about 3367-3378 cm-1 (Koç, 2011[11]). The vibrations of the triazine C=N and O-H of the CCDOP1 and CCDOP3 were observed at 1551, 1567 and 3340, 3358 cm-1 range, respectively (Disley et al., 1999[5]; Koç, 2011[11]).

The thermal stabilities of compounds CCDOP1 and CCDOP3 were also thermally investigated and their plausible degrading (Koç, 2011[11]; Koç and Uysal, 2010[13], 2011[14]; Uysal and Koç, 2010[33]) schemes are presented in Table 1(Tab. 1). Thermal decomposition of the anhydrous compounds starts in the range of 98-412 oC and completes in the range 900 oC. The observed weight losses for all compounds are in good agreement with the calculated values.

In this study, the antimicrobial activities of CCDOP1, CCDOP3 and DOP were investigated by microbroth dilution method according to Maltaş et al. (2010[19]) against eight bacteria and one yeast. The obtained results are presented in Table 2(Tab. 2) and Figure 2(Fig. 2).

CCDOP1 was found to be strongly antibacterial against E. coli and S. aureus at a 0.0396 mg/ml dose level. Ampicillin control antibiotic was equally effective against these two bacteria. The MIC value of chemical was determined as 1.25 mg/ml for Streptococcus salivarius. While Ampicillin had no effect on this strain, our chemical was found to be more effective than the antibiotic. For P. mirabilis the MIC value was determined as 2.50 mg/ml. The control antibiotic influenced this strain at a 1.25 mg/ml dose level. Although P. aeruginosa was found to be resistant to the control antibiotic at all test doses, it was affected by CCDOP1 at a 2.50 mg/ml dose level. The MIC value was 2.50 mg/ml for K. oxytoca and B. cereus, too. It has been seen that CCDOP1 revealed a similar effect against K. oxytoca when compared with the standard antibiotic. Though L. monocytogenes was resistant to the antibiotic, CCDOP1 had antimicrobial capacity against this strain at a 2.50 mg/ml dose level. In addition to its antibacterial effect, our chemical had antifungal capacity against Candida albicans which is yeast and used in the study at a concentration of 2.50 mg/ml.

The MIC values of CCDOP3 were determined as 0.625 mg/ml against E. coli and S. aureus. CCDOP3 was more effective than CCDOP1 against K. oxytoca, B. cereus, L. monocytogenes and Candida albicans at a concentration of 1.25 mg/ml. This chemical had strong antibacterial and antifungal activities as well as the control antibiotic against K. oxytoca and Candida albicans, respectively. The MIC values were determined as 2.50 mg/ml for P. mirabilis and P. aeruginosa.

Dopamine hydrochloride exhibited strong antibacterial activity against S. aureus at a concentration of 0.0195 mg/ml. It was found to be more effective than Ampicillin. E. coli was affected by dopamine hydrochloride at a dose of 0.156 mg/ml. It had similar antimicrobial activity against other bacteria and Candida when compared with CCDOP3.


In this study, CCDOP1, CCDOP3 were synthesized by the reaction of cyanuric chloride and dopamine hydrochloride according to the literature (Naicker et al., 2004[23]; Koç, 2011[11]; Disley et al., 1999[5]; Teng et al., 2000[32]; Fang et al., 2001[6]). The structures of the compounds were identified by FT-IR, 1H NMR, 13C NMR, thermal analysis and elemental analysis. According to the results obtained from the broth microdilution test, it has been determined that CCDOP1, CCDOP3 and DOP revealed strong antibacterial activity against the E. coli and S. aureus strains used in the study. CCDOP1 and DOP have significant antimicrobial activity and these effects are close to the control antibiotic used. S. aureus was the most sensitive strain against dopamine hydrochloride and E. coli was the most sensitive bacteria against CCDOP1. CCDOP3 was more effective than the other chemicals tested against all microorganisms except for E. coli and S. aureus. Although they were resistant to the antibiotic, P. aeruginosa, L. monocytogenes and especially Str. salivarius were significantly affected by CCDOP1, CCDOP3 and DOP. It was determined that these chemicals have antifungal capacities, too.



1. Agarwal A, Srivastava K, Puri SK, Chauhan PMS. Antimalarial activity and synthesis of new trisubstituted pyrimidines. Bioorg Med Chem Lett. 2005;15:3130-2.
2. Agarwal A, Srivastava K, Puri SK, Chauhan PMS. Synthesis of 2,4,6-trisubstituted pyrimidines as antimalarial agents. Bioorg Med Chem Lett. 2005;13:4645-5031.
3. Baliani A, Bueno, GJ, Stewart ML, Yardley V, Brun R, Barrett MP, Gilbert IHJ. Design and synthesis of a series of melamine-based nitroheterocycles with activity against trypanosomatid parasites. J Med Chem. 2005;48:5570-9.
4. Chang C, Huang C, Huang Y, Lin K, Lee Y, Wang C. Total synthesis of (±)-armepavines and (±)-nuciferines from (2-nitroethenyl)benzene derivatives. Synthetic Commun. 2010;40:3452-66.
5. Disley DM, Morrill PR, Sproule K, Lowe CR. An optical biosensor for monitoring recombinant proteins in process media. Biosens Bioelectron. 1999;14:481-93.
6. Fang Q, Ding X, Wu X, Jiang L. Synthesis and characterization of a novel functional monomer containing two allylphenoxy groups and one S-triazine ring and the properties of its copolymer with 4,4'-bismaleimidodiphenylmethane (BMDPM). Polymer. 2001;42:7595-602.
7. Ghaib A, Ménager S, Vérité P, Lafont O. Synthesis of variously 9,9-dialkylated octahydropyrimido [3,4-a]-s-triazines with potential antifungal activity. Farmaco. 2002;57:109–16.
8. Hadjipavlou-Litina DH, Magoulas GE, Bariamis SE, Drainas D, Avgoustakis K, Papaioannou D. Does conjugation of antioxidants improve their antioxidative/ anti-inflammatory potential? Bioorg Med Chem. 2010;18:8204-17.
9. Henke BR, Consler TG, Go N, Hale RL, Hohman DR, Jones SA, et al. A new series of estrogen receptor modulators that display selectivity for estrogen receptor beta. J Med Chem. 2002;45:5492–505.
10. Jensen NP, Ager AL, Bliss RA, Canfield CJ, Kotecka BM, Rieckmann KH, et al. Phenoxypropoxybiguanides, prodrugs of DHFR-inhibiting diaminotriazine antimalarials. J Med Chem. 2001;44:3925–31.
11. Koç ZE. Complexes of iron(III) and chromium(III) salen and salophen Schiff bases with bridging 1,3,5-triazine derived multidirectional ligands. J Heterocyclic Chem. 2011;48:769-75.
12. Koç ZE, Bingol H, Saf AO, Torlak E, Coskun A. Synthesis of novel tripodal-benzimidazole from 2,4,6-tris(p-formylphenoxy)-1,3,5-triazine: structural, electrochemical and antimicrobial studies. J Hazard Mater. 2010;183:251-5.
13. Koç ZE, Uysal S. Synthesis and characterization of dendrimeric bridged salen/saloph complexes and ınvestigation of their magnetic and thermal behaviors. Helv Chim Acta. 2010;93:910-9.
14. Koç ZE, Uysal S. Synthesis and characterization of tripodal oxy-schiff base (2,4,6-tris(4-Carboxymethylenephenylimino-4′-formylphenoxy)-1,3,5-triazine) and the thermal and magnetic properties of its Fe(III)/Cr(III) complexes. J Inorg Organomet P. 2011;21:400-6.
15. Kumar A, Menon SK. Fullerene derivatized s-triazine analogues as antimicrobial agents. Eur J Med Chem. 2009;44:2178-83.
16. Kuo GH, DeAngelis A, Emanuel S, Wang A, Zhang Y, Connolly PJ, et al. Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitors. J Med Chem. 2005;48:4535-46.
17. Lebreton S, Newcombe N, Bradley M. Antibacterial single-bead screening. Tetrahedron. 2003;59:10213–22.
18. Lübbers T, Angehrn P, Gmünder H, Herzig S, Kulhanek. Design, synthesis, and structure–activity relationship studies of ATP analogues as DNA gyrase inhibitors. Bioorg Med Chem Lett. 2000;10:821–6.
19. Maltaş E, Uysal A, Yıldız S, Durak Y. Evaluation of antioxidant and antimicrobial activity of Vitex agnus castus L. Fresen Environ Bull. 2010;19:3094-9.
20. McKay GA, Reddy R, Arhin F, Belley A, Lehoux D, Moeck G, et al. Triaminotriazine DNA helicase inhibitors with antibacterial activity. Bioorg Med Chem Lett. 2006;16:1286-90.
21. Menicagli R, Samaritani S, Signore G, Vaglini F, Dalla Via L. In vitro cytotoxic activities of 2-alkyl-4,6-diheteroalkyl-1,3,5-triazines: new molecules in anticancer research. J Med Chem. 2004;47:4649-52.
22. Mooibroek TJ, Gamez P. The s-triazine ring, a remarkable unit to generate supramolecular interactions. Inorg Chim Acta. 2007;360:381-404.
23. Naicker KP, Jiang S, Lu H, Ni J, Chatenet LB, Wang LX, et al. Synthesis and anti-HIV-1 activity of 4-[4-(4,6-bisphenylamino-triazin-2-ylamino)-5-methoxy-2-methylphenylazo]-5-hydroxynaphthalene-2,7-disulfonic acid and its derivatives. Bioorg Med Chem. 2004;12:1215-20.
24. Ojha H, Gahlot P, Tiwari AK, Pathak M, Kakkar R. Quantitative structure activity relationship study of 2,4,6-trisubstituted-s-triazine derivatives as antimalarial inhibitors of Plasmodium falciparum dihydrofolate reductase. Chem Biol Drug Des. 2011;77:57-62.
25. Pająk M, Kańska M. Synthesis of isotopomers of dopamine labeled with deuterium or tritium. J Labelled Compd Rad. 2006;49:1061-7.
26. Pandey VK, Tusi S, Tusi Z, Joshi M, Bajpai S. Synthesis and biological activity of substituted 2,4,6-s-triazines. Acta Pharm. 2004;54:1–12.
27. Patel HS, Patel VC. Polyimides containing s-triazine ring. Eur Polym J. 2001;37:2263-71.
28. Solankee A, Kapadia K, Ciric A, Sokovic M, Doytchinova I, Geronikaki A. Synthesis of some new S-triazine based chalcones and their derivatives as potent antimicrobial agents. Eur J Med Chem. 2010;45:510-8.
29. Srinivas K, Srinivas U, Rao VJ, Bhanuprakash K, Kishore KH, Murty USN.Synthesis and antibacterial activity of 2,4,6-tri substituted s-triazines. Bioorg Med Chem Lett. 2005;15:1121–3.
30. Srivastava S, Tewari S, Chauhan PMS, Puri SK, Bhaduri AP, Pandey VC. Synthesis of bisquinolines and their in vitro ability to produce methemoglobin in canine hemolysate. Bioorg Med Chem Lett. 1999;9:653-8.
31. Srivastava S, Tewari S, Srivastava SK, Chauhan PMS, Bhaduri AP, Puri SK, et al. Synthesis of 7-chloro-4-substituted aminoquinolines and their in-vitro ability to produce methemoglobin in canine hemolysate. Bioorg Med Chem Lett. 1997;7:2741.
32. Teng SF, Sproule K, Husain A, Lowe CR. Affinity chromatography on immobilized "biomimetic" ligands. Synthesis, immobilization and chromatographic assessment of an immunoglobulin G-binding ligand. J Chromatogr B Biomed Sci Appl. 2000;740:1–15.
33. Uysal Ş, Koç ZE. Synthesis and characterization of dendrimeric melamine cored [salen/salophFe(III)] and [salen/saloph Cr(III)] capped complexes and their magnetic behaviors. J Hazard Mater. 2010;175:532-9.
34. Xie J, Xu C, Kohler N, Hou Y, Sun S. Controlled PEGylation of monodisperse Fe3O4 nanoparticles for reduced non-specific uptake by macrophage cells. Adv Mater. 2007;19:3163-6.

Figure 1: Proposed structures of the monopodal and tripodal s-triazines

Figure 2: Graphic of antimicrobial activity test results


Table 1: Decomposition steps with the temperature range and weight loss for monopodal and tripodal s-triazines

Table 2: Results of antimicrobial activities of CCDOP1, CCDOP3, DOP and standard antibiotic

[*] Corresponding Author:

Assist. Prof. Mustafa Onur Aladag, Department of Medicinal Laboratory,Vocational School of Health Services, Selcuk University, 42031 Campus, Konya, Turkey. phone:+905383176017, fax: +903322416210, eMail: